All Episodes
Pharmacy in a Minute - Get your daily dose of news and information — 168 episodes
PBM Audits on the Rise
Metabolic dysfunction–associated steatotic liver disease (MASLD)
The Dispensing Model Is Breaking
Pets Are Big Business
MFP, PBMs & Why Data Matters More Than Ever
Why KPIs Matter More Than Instinct
The Biggest Challenges Facing Retail Pharmacy
The Rise of "Pharmacy Deserts" Across America
Retail Pharmacy Faces a Brain Drain
HRT BLACK-BOX UPDATE
THE BREAKFAST DEBATE: ULTRA-PROCESSED OR JUST SUGARY?
The Future of Compounding Starts Here
Turnkey Compounding Made Easy
Pet Meds — The Golden Opportunity
The Rise of AI in Pharmacy
Your Pharmacy's Hidden Goldmine: The Untapped Power of Data
The New Rules for Running a Successful Pharmacy in 2025
The Untapped Goldmine: Telemedicine in Independent Pharmacy
The PBM Playbook: How Middlemen Are Fleecing Independent Pharmacies
Pharmacies at the Center of the Weight-Loss Revolution
Eli Lilly Partners with Walmart to Expand Access to Weight-Loss Drug Zepbound
Amazon layoffs could top 30,000
Physician Burnout Deepens — Pharmacies Poised to Bridge the Gap
GLP-1 Coverage Tightens Nationwide
Low-Dose Naltrexone in Cancer Care
Adapting to Local Needs
AB 1503 — Pharmacist Reimbursement Reform
AstraZeneca's Push for Farxiga® Records
CVS Caremark Sued Over Zepbound Coverage Cut
How Supplements Can Aid in the Weight-Loss Journey
Lead Smarter with Causal Thinking
Big Chains tightening who can get a vaccine
Medication mistakes
Walgreens store closure - Means another opportunity for independent pharmacies
The Crisis No One Can Ignore
When Pharmacies Cut Corners, Federal Enforcement Steps In
GLP-1s on the Rise
Pet Owners Are Spending Big — Your Pharmacy Can Profit
Monitoring Hazardous Drug Residues in Compounding
CMS: MTF DM Required, Not MDPNP Dispensing
FDA Tightens Opioid Labels
The Crisis at the pharmacy counter
Teva Launches Generic Dificid
Powerful Yet Often Underused Tool—Professionally Written Press Releases
New Program to Help Boost Cash Business
Turnkey Text Messaging Now Available!
Boost Profits with Telemedicine + Supplements
Unlock Compounding Profits Without Compounding In-House
Pharmacists Reduce Discharge Prescription Errors for Diabetes Patients
CVS Caremark to pay $95M in Medicare fraud case
The Evolving Role of the Pharmacist
GLP-1 Dispensing Risks – Stay Ahead of the Curve
Defensive Strategies to Survive Audits & Protect Your License
State Boards & PBM Referrals – What You Need to Know
PBM Audit Tactics – What You Need to Know
Powerful impact of pharmacist-managed care on diabetes outcomes
Always Verify Details When Receiving Transferred Prescription
Amneal releases generic Byetta
Retail Pharmacies Turn to AI
Rite Aid's Big Pharmacy Sell-Off
Major Shift in Arkansas Pharmacy
UnitedHealth Group Under DOJ Investigation for Medicare Advantage Fraud
Contract Evaluation Best Practices for Community Pharmacies
Trump Targets Drug Price Cuts
Texas Pharmacist Sentenced to Over 17 Years for $170 Million DOL Fraud
CVS Caremark Drops Zepbound
High-Protein Diets Gain Attention for Weight Loss and GLP-1
May is Mental Health Awareness Month
Nicotine pouch use rises among U.S. teens
Boost Pharmacy Profits with Smart Front-End Strategies
Independent Pharmacies Brace for Tariff Fallout
Independent Pharmacies Grapple with Escalating Crisis
How You Do Anything Is How You Do Everything
How to reduce dependence on PBM revenue
FDA Enforcement Discretion Ending
FDA Issues Warning on Compounded Topical Finasteride
Retatrutide & the Rules of Compounding
More Pharmacies Race to Offer Same-Day Prescription Deliveries
PBM Policy Change
Stop Listening to Respond
The Language War on Compounded Drugs
What Your Face Might Be Saying
How to Reduce Dependence on PBM Revenue
Effective Pharmacy Management
The Hidden Cost of Coupon Cards
The Power of Listening
Insomnia and Obstructive Sleep Apnea: Key Updates
FDA Warns of Counterfeit Ozempic in U.S. Supply Chain
New Blood Test May Aid in Diagnosing and Tracking Alzheimer's
Low-Dose Doxycycline Effective for Alopecia
GLP-1 Drugs Lower Epilepsy Risk
Liraglutide Lowers Stroke Recurrence in T2D
GLP-1 Meds Linked to Reduced Risk for Dementia
The Power of Consistency
The Evolving Role of Pharmacists
Settlement Reached in Hi-School Pharmacy Data Breach
The power of having a great conversation
You're a Pharmacy Owner Trying to Hit $100K/Month in Recurring Revenue
Leadership Check-In: Do You Know Your Boundaries?
Want more opportunities: Get comfortable being uncomfortable
Novo Nordisk: New GLP
503B Outsourcing Facilities: A Critical Solution to Ongoing Drug Shortage
UnitedHealth to Boost Brand Name Drug Reimbursements
PBMs Inflated Drug Prices - Reaped $7.3 billion
Discipline Drives Pharmacy Leadership
HALT Fentanyl Act Moves Forward
NADAC and the advances in New Mexico for Independent Pharmacies
How to Reprogram Your Mind for Success
DEA Issues Alert on EHR Hacking and Prescription Fraud
Critical FDA Update on Semaglutide
3 Steps to Building a Clinical Practice in Your Retail Pharmacy
Why Your Pharmacy Needs a Strong Digital Presence
Tirzepatide Off FDA Shortage List – What's Next for Pharmacies?
Novo Nordisk announcing price reduction
Chronic pain linked with depression and anxiety
Prescription Drug Rebate Impact to Commercial Health Insurance
PBM Price Transparency Saves Money
The Cost of Inaction When a Pharmacy Does Nothing as Sales Decline
The Power of Voice in Communication
How to Properly Bill for Wasted Drugs
GLP-1 Shortage, Battle Rages on
First U.S. Measles Death in 10 Years Reported in Texas Outbreak
FDA clarifies policies for compounders as national GLP-1 supply begins to stabilize
4 Ways to Avoid a Medicare Ban
Navigating Pharmacy Audits in 2025
Increased Inspections for GLP-1 Compounding
Ongoing Legal Battles Over Tirzepatide Compounding
FDA Removes Tirzepatide from Shortage
Inflation Reduction Act also known as IRA
DEA Announces Three New Telemedicine Rules that Continue to Open Access to Telehealth Treatment while Protecting Patients
Wisconsin couple sues Walgreens and Optum Rx, saying son died after $500 price rise for asthma meds
The Risk of Using Aberrant Drugs in Third-Party Billing
PBM those Dreaded Three Little Letters
Fasting Plasma Glucose Level Is Associated With Development of Diabetes
Triple–Hormone-Receptor Agonist Retatrutide for Obesity
Mindfulness Program Reduces Opioid Cravings During Buprenorphine Treatment
Emotional Intelligence: A hidden key to leadership
Lupin receives FDA OK for generic Banzel
Salt substitutes as a way to lower risk of death
FDA Announces Class I Recall of Systane Lubricant Eye Drops
Pfizer has issued a voluntary recall of Inflectra a biosimilar to Remicade
The Benefits of Offering Animal Medications at Your Pharmacy
JournaVx: Breakthrough in Pain Management approved by FDA
PBMs Are Once Again Under Fire
FDA Expands Ozempic Approval in Diabetes and Kidney Disease
Medicare Drug Price Negotiation
PBMs are Under Fire Again!
Point-of-Care Testing
Expanding Your Pharmacy with Specialized Programs
The Power of Networking in Your Community
The Power of a Consistent Marketing Plan
Clawbacks & Low Reimbursements
The GLP-1 Craze & Its Impact on Pharmacy
High Deductible Health Plans
Opioid Use Disorder
Burning Topics in Pharmacy
Expanding Pharmacy Services in Dermatology
Physician Marketing Best Practices
Brain Drain in Pharmacy
Cost Effective Pharmacy Delivery
Key Performance Indicators in Pharmacy
Drug Transparency
Hazardous Materials at Work Place
What Pharmacies are Getting Wrong!
The PBM Challenge Facing Pharmacies
Enhancing Pharmacy Customer Service
Benefits of AI in Pharmacy
Cost Plus Model for Pharmacies